Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Gut and Liver|April 21, 2017
Current Trends in the Management of Gastroesophageal Reflux DiseaseDalbir S Sandhu, Ronnie FassCurrent Gastroenterology Reports|April 18, 2008
Diagnosis and management of cholangiocarcinomaDalbir S Sandhu, Lewis R RobertsJournal of Clinical Gastroenterology|March 24, 2022
The Discrepancy Between Subjective and Objective Clinical Endpoints in Gastroesophageal Reflux DiseaseFahmi Shibli, Dalbir S Sandhu, Ronnie FassWorld Journal of Gastroenterology|June 2, 2020
Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive reviewMing Han Cha, Miguel Regueiro, Dalbir S SandhuHepatology (Baltimore, Md.)|April 10, 2014
Fibroblast growth factor signaling in liver carcinogenesisDalbir S Sandhu, Esha Baichoo, Lewis R RobertsMinerva Gastroenterologica E Dietologica|October 11, 2017
Underwater endoscopic mucosal resection: an alternative treatment for large colorectal polyp removalDalbir S Sandhu, Ye J Lee, Henning GerkeLiver International : Official Journal of the International Association for the Study of the Liver|November 23, 2007
Epigenetic DNA hypermethylation in cholangiocarcinoma: potential roles in pathogenesis, diagnosis and identification of treatment targetsDalbir S Sandhu, Abdirashid M Shire, Lewis R RobertsJournal of Gastrointestinal Cancer|April 18, 2009
The tumor suppressor function of human sulfatase 1 (SULF1) in carcinogenesisJin-Ping Lai, Dalbir S Sandhu, Abdirashid M Shire, et al.Endoscopy International Open|July 5, 2021
Underutilization of prophylactic rectal indomethacin and pancreatic duct stent for prevention of post-ERCP PancreatitisAbdulfatah Issak, Abbinaya Elangovan, Roy D Ferguson, et al.Future Oncology (London, England)|December 18, 2008
Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targetsJin-Ping Lai, James R Thompson, Dalbir S Sandhu, et al.Pageof 3